Manufacturing depression (67 page)

British Medical Journal,
276

British National Institutes for Health and Clinical Excellence,
204

British Psychological Society,
166

Broadhurst, Alan,
182
,
187

Broca, Paul,
325
,
326

Bronk, Detlev,
5

Brown, John,
323

Bush, George W.,
39

California, University of,
278

California Medical Board,
322

Callahan, Christopher,
261

Calvin, John,
122

Calvinism, pharmacological,
192
,
193
,
265
,
267
,
310
,
348
,
355

Campbell, Alan,
133

Camphor,
140
–41

Cardiazol,
144

Carlsson, Arvid,
10
,
12
,
194
–95,
198
,
267
–69,
335

Carter’s Little Liver Pills,
260

Catecholamines,
169
,
195
–99,
205
,
224

Celexa,
42
,
270

Centers for Disease Control (CDC),
10
,
15

Central Intelligence Agency (CIA),
164

Cerebellum,
319
,
321

Cerletti, Ugo,
142
–46

Change Your Brain, Change Your Life
(Amen),
318

Charcot, Jean,
83
,
90
,
98
,
150

Charité Hospital (Berlin),
50
,
55
,
67

Charles Pfizer and Company,
59

Chemie Grünenthal,
213

Chestnut Lodge,
298
–99

Chicago, University of,
82
,
83
,
85

Chlorothiazide,
59

Chlorpromazine (Thorazine),
180
–83,
191

Cholera,
50

Cingulate gyrus,
319
,
321
,
328
,
330

City of London School,
45

Civilization and Its Discontents
(Freud),
119
–20,
123
,
173

Clark, Dick,
358

Clark University,
83

Clayton, Paula,
246
,
248

Clemens, Samuel,
see
Twain, Mark

Cleveland, Grover,
84

Cleveland Clinic,
4

Clinical trials,
40
–42,
109
,
135
,
164
,
228

basic assumptions of,
131

of cognitive therapy,
288
,
297
,
302
–5

diagnosis for,
41
,
48
,
61
–63,
348
,
350

FDA approval and,
270

intake interviews for,
170

marketing and,
262

placebo effect in,
8
,
109
,
201
–4,
219
,
254
–56,
280
,
284
–86,
306
,
316

randomized,
202
,
216
,
218
–24

signal-to-noise ratio in,
355

statistical procedures in,
307

theoretical foundations for,
174
–75

Coal tar,
46
–47

see also
Aniline

Cognitive-behavioral therapy,
116
,
252
,
364

Cognitive Therapist Rating Scale,
302

Cognitive therapy,
286
–98,
302
–16,
334

Cognitive Therapy: Basics and Beyond
(Beck),
292

Collier’s
magazine,
206

Columbia Psychoanalytic Institute,
240

Columbia University,
336

Columbus, Christopher,
55

Commonsense psychiatry,
95
–97

Communism,
266

Computerized tomography (CT),
317

Congress, U.S.,
188
,
190
–91,
208
,
209
,
211
,
215

Consciousness,
103
,
128
,
163
,
223

altered states of,
176
–78 (
see also
LSD; MDMA)

brain structures and,
66
,
322
,
351

collective,
20

depression and,
231
,
282

public,
144

Consumer Reports,
300

Copernicus,
337

Cornell University,
219

Corticosteroids,
212

Cortisol,
346

Cosmopolitan
magazine,
274

Countergan,
213

see also
Thalidomide

Cronkite, Kathy,
358
–60

Cronkite, Walter,
358

Cuforhedake Brane-Fude,
205
,
207

Cullen, William,
242

Cytokine,
327

Darkness Visible
(Styron),
29

Darwinism,
92

Death instinct,
119

Deep brain stimulation,
327
–28,
347

Delusions,
19
,
70
,
77
,
87
,
138
,
147

Delysid,
163
–65

see also
LSD

Dementia praecox,
71
,
78

Democratic Party,
84
,
212

Depression and Bipolar Support Alliance (DBSA),
357
–61

Depression and Clinical Research Group,
201

Depressionisreal.org,
22

Descartes, René,
4
,
351

Dewey, John,
87

Dewey, Richard,
84

Diabenes,
191

Diabetes,
18
,
36
,
191
,
231
,
252
,
281
–82,
317
,
359

insulin and,
59
,
281

Diagnostic and Statistical Manual of Mental Disorders
(American Psychiatric Association),
14
–15,
18
,
62
–63,
170
–73,
189
,
227
,
232
,
233
,
251
–52,
278
,
295
,
304
,
343
–49,
355

second edition (DSM-II),
62
,
236
,
238
–39

third edition of (DSM-III),
14
,
19
,
239
–47,
250
,
252
,
262
,
267
,
299
,
316
,
343

fourth edition of (DSM-IV),
15
,
38
,
42
,
61
,
132
,
250
,
316
,
345

fifth edition of (DSM-V),
15
,
39
,
320
,
345
,
346
,
349

Dirksen, Everett,
191
,
193
,
212

Diuril,
59

DNA,
69

Dobson, Keith,
309

Dr. Johnson’s Mild Combination Treatment for Cancer,
207
–8

Donaldson, H. H.,
83

Dopamine,
194
–95,
198
,
267
,
320
–21,
327

Dording, Christina,
102
–4,
106
,
130
–32,
227
,
283
–84,
286

Double-blind studies,
202
,
220
,
222
,
326
,
364

Down & Up Show
(podcast),
11
–12

Dreyfus, Georges,
76
–79

Drug Enforcement Administration (DEA),
266
,
381
n

DuBois, W.E.B.,
91

Dyes,
48
–50,
195
,
198

Dysthymic disorder,
243
,
244
,
313

East India Company,
47

Ecstasy,
see
MDMA

Eddy, Mary Baker,
91

Edison, Thomas,
92

Edwards, Jonathan,
192
n

Effexor,
109
,
271
,
276
–77,
320

Ego psychology,
121
–22

Ehrlich, Paul,
48
–50,
52
–55,
57
–60,
90
,
161
,
179
,
199
,
208
,
209

Elavil,
261
–62,
264
,
265

Electroconvulsive therapy (ECT),
144
,
146
–47,
150
,
151
,
177
,
347

origins of,
140
–42

Eli Lilly and Company,
10
,
38
–39,
59
,
81
,
164
,
268
,
269
,
272
–75

Eliphaz,
28
,
31
–32,
34
–35,
37
,
97
,
101
,
121
,
314
,
334
,
339
,
367

Elixir Sulfanilamide,
209
,
210

Elkin, Stanley,
110

Ellis, Havelock,
133
–36,
148

Emerson, Ralph Waldo,
323

Empathy,
73
,
89
,
326

in cognitive therapy,
294
,
301
,
303
,
309

Kraepelin’s rejection of,
65
,
70

risks of,
98
,
106

Empirically supported therapies (ESTs),
302
,
305
–6,
308
,
310

Endogenous depression,
183
–85,
189